The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
New biomarkers of acute kidney injury
Abstract
Acute kidney injury (AKI) represents a major clinical problem, with rising incidence and high mortality rate. The lack of early biomarkers has resulted in a delay in initiating therapies. Fortunately, the tools of modern science have revealed promising novel biomarkers for AKI, with potentially high sensitivity and specificity. These include a plasma panel (neutrophil gelatinase-associated lipocalin and cystatin C) and a urine panel (neutrophil gelatinase-associated lipocalin, interleukin 18, and kidney injury molecule-1). Because they represent sequential biomarkers, it is likely that the AKI panels will be useful for timing the initial insult and assessing the duration of AKI (analogous to the cardiac panel for evaluating chest pain) and for predicting overall prognosis with respect to dialysis requirement and mortality. It is also likely that the AKI panels will help distinguish between the various types and pathogeneses of AKI. It will be important in future studies to validate the sensitivity and specificity of these biomarker panels in clinical samples from large cohorts and from multiple clinical situations. Such studies will be markedly facilitated by multidisciplinary participation of various specialties (intensivists, cardiologists, surgeons) in AKI clinical studies and by the availability of commercial tools for the reliable and reproducible measurement of biomarkers across different laboratories.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Uchino, S. (2005) · JAMA · doi:10.1001/jama.294.7.813 · Cited by 4,176
Vincent, J.-L., de Mendonca, A., Cantraine, F., Moreno, R., Takala, J., Suter, P. M., Sprung, C. L., Colardyn, F., & Blecher, S. (1998) · Critical Care Medicine · doi:10.1097/00003246-199811000-00016 · Cited by 3,463
Mishra, J., Dent, C., Tarabishi, R., Mitsnefes, M. M., Ma, Q., Kelly, C., Ruff, S. M., Zahedi, K., Shao, M., Bean, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74811-x · Cited by 2,394
Self-citationHospital-acquired renal insufficiency
Nash, K., Hafeez, A., & Hou, S. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32766 · Cited by 1,951
Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury
Han, W. K., Bailly, V., Abichandani, R., Thadhani, R., & Bonventre, J. V. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00433.x · Cited by 1,929
Mishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J., & Devarajan, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088027.54400.c6 · Cited by 1,749 · cited 1×
“NGAL was recently identified by micro-array analysis as one of the earliest and most robustly induced genes and proteins in the kidney after ischemic or nephrotoxic injury in animal models, and NGAL protein was easily detected in the blood and urine soon after AKI (53, 62).”
BackgroundSelf-citationPhases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686 · cited 1×
“(52) for cancer-related biomarkers, but the principles can be applied for development of biomarkers for other pathophysiologic states such as AKI.”
BackgroundThe effect of acute renal failure on mortality. A cohort analysis
Levy, E. M. (1996) · JAMA · doi:10.1001/jama.275.19.1489 · Cited by 1,660
Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by Acetylcysteine
Tepel, M., van der Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., & Zidek, W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430304 · Cited by 1,588
Thadhani, R., Pascual, M., & Bonventre, J. V. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342207 · Cited by 1,417
Cited by
Pathophysiology of Acute Kidney Injury
Basile, D. P., Anderson, M. D., & Sutton, T. A. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110041 · Cited by 1,094
Li, S., Krawczeski, C. D., Zappitelli, M., Devarajan, P., Thiessen-Philbrook, H., Coca, S. G., Kim, R. W., & Parikh, C. R. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821201d3 · Cited by 483
Self-citationUrinary Biomarkers in the Early Detection of Acute Kidney Injury after Cardiac Surgery
Han, W. K., Wagener, G., Zhu, Y., Wang, S., & Lee, H. T. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04810908 · Cited by 413
Augmented Renal Clearance: Implications for Antibacterial Dosing in the Critically Ill
Udy, A. A., Roberts, J. A., Boots, R. J., Paterson, D. L., & Lipman, J. (2010) · Clinical Pharmacokinetics · doi:10.2165/11318140-000000000-00000 · Cited by 377
Urinary Biomarkers in the Clinical Prognosis and Early Detection of Acute Kidney Injury
Koyner, J. L., Vaidya, V. S., Bennett, M. R., Ma, Q., Worcester, E., Akhter, S. A., Raman, J., Jeevanandam, V., O'Connor, M. F., Devarajan, P., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00740110 · Cited by 370
Self-citationDEVARAJAN, P. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01317.x · Cited by 356
Self-citationLiu, K. D., Thompson, B. T., Ancukiewicz, M., Steingrub, J. S., Douglas, I. S., Matthay, M. A., Wright, P., Peterson, M. W., Rock, P., Hyzy, R. C., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318228234b · Cited by 355
Dieterle, F., Perentes, E., Cordier, A., Roth, D. R., Verdes, P., Grenet, O., Pantano, S., Moulin, P., Wahl, D., Mahl, A., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1622 · Cited by 334
Neutrophil Gelatinase-Associated Lipocalin: A� Promising Biomarker for Human Acute Kidney Injury
Devarajan, P. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.12 · Cited by 332
Self-citationAcute Kidney Injury Reduces Survival in Very Low Birth Weight Infants
Koralkar, R., Ambalavanan, N., Levitan, E. B., McGwin, G., Goldstein, S., & Askenazi, D. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e31820b95ca · Cited by 314
Biomarkers Predict Progression of Acute Kidney Injury after Cardiac Surgery
Koyner, J. L., Garg, A. X., Coca, S. G., Sint, K., Thiessen-Philbrook, H., Patel, U. D., Shlipak, M. G., & Parikh, C. R. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011090907 · Cited by 292
Self-citationBiomarkers for the early detection of acute kidney injury
Devarajan, P. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328343f4dd · Cited by 284
Self-citationEndre, Z. H., Walker, R. J., Pickering, J. W., Shaw, G. M., Frampton, C. M., Henderson, S. J., Hutchison, R., Mehrtens, J. E., Robinson, J. M., Schollum, J. B. W., et al. (2010) · Kidney International · doi:10.1038/ki.2010.25 · Cited by 271
The evaluation of renal function and disease in patients with cirrhosis
Francoz, C., Glotz, D., Moreau, R., & Durand, F. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.025 · Cited by 256
Sepsis and Acute Kidney Injury
Bilgili, B., Haliloglu, M., & Cinel, I. (2014) · Turkish Journal of Anesthesia and Reanimation · doi:10.5152/tjar.2014.83436 · Cited by 42
“It is thought that urinary IL-18 levels are more specific for ischemic AKI and not affected by chronic kidney injury, urinary tract infection or nephrotoxic damage (58).”
BackgroundCD4(+) T cell-derived NGAL modifies the outcome of Ischemic acute kidney Injury
Lee, S. A., Noel, S., Kurzhagen, J. T., Sadasivam, M., Pierorazio, P. M., Arend, L. J., Hamad, A. R., & Rabb, H. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900677 · Cited by 41
Udawatte, N. S., Kang, S. W., Wang, Y., Arumugam, T. V., & Seneviratne, C. J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00511 · Cited by 17
Metadata
- Authors
- Parikh, C. R., & Devarajan, P.
- Venue
- Critical Care Medicine
- Published
- 2008-04
- Volume
- 36
- Issue
- Suppl
- Pages
- S159-S165
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2010668846
- Cited by
- 281
- References
- 70
- FWCI
- 20.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.